Viewing Study NCT05662904


Ignite Creation Date: 2025-12-24 @ 7:59 PM
Ignite Modification Date: 2025-12-25 @ 5:33 PM
Study NCT ID: NCT05662904
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-03-14
First Post: 2022-12-06
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Genetic Ablation of CD33 in HSC to Broaden the Therapeutic Index of CD33-directed Immunotherapy in Patients with AML
Sponsor: German Cancer Research Center
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2028-01
Start Date Type: ESTIMATED
Primary Completion Date: 2029-01
Primary Completion Date Type: ESTIMATED
Completion Date: 2030-01
Completion Date Type: ESTIMATED
First Submit Date: 2022-12-06
First Submit QC Date: None
Study First Post Date: 2022-12-23
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-03-12
Last Update Post Date: 2025-03-14
Last Update Post Date Type: ACTUAL